Atrial Fibrillation Agents: Better Drugs For The Arrhythmic Heart
This article was originally published in Start Up
Executive Summary
Improvements in targeting the sources of aberrant cardiac rhythms may open the heart up to new therapies. In this issue, we profile four start-ups focused on developing treatments for AF and other arrhythimas: Acesion Pharma, ChanRx, Milestone Pharmaceuticals and Serodus.